These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16172698)

  • 1. Design and synthesis of a DNA-crosslinking azinomycin analogue.
    Casely-Hayford MA; Pors K; James CH; Patterson LH; Hartley JA; Searcey M
    Org Biomol Chem; 2005 Oct; 3(19):3585-9. PubMed ID: 16172698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of DNA sequence selectivity and cell cytotoxicity on azinomycin A and B epoxyamide stereochemistry.
    Coleman RS; Woodward RL; Hayes AM; Crane EA; Artese A; Ortuso F; Alcaro S
    Org Lett; 2007 May; 9(10):1891-4. PubMed ID: 17432865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated azinomycin analogues intercalate into DNA.
    Casely-Hayford MA; Pors K; Patterson LH; Gerner C; Neidle S; Searcey M
    Bioorg Med Chem Lett; 2005 Feb; 15(3):653-6. PubMed ID: 15664831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azinomycin inspired bisepoxides: influence of linker structure on in vitro cytotoxicity and DNA interstrand cross-linking.
    LePla RC; Landreau CA; Shipman M; Hartley JA; Jones GD
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2861-4. PubMed ID: 15911269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of DNA cross-linking analogues based on the azinomycin scaffold.
    Alcaro S; Ortuso F; Coleman RS
    J Chem Inf Model; 2005; 45(3):602-9. PubMed ID: 15921450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating noncovalent interactions between the azinomycins and double-stranded DNA: importance of the naphthalene substitution pattern on interstrand cross-linking efficiency.
    Landreau CA; LePla RC; Shipman M; Slawin AM; Hartley JA
    Org Lett; 2004 Sep; 6(20):3505-7. PubMed ID: 15387534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA binding and alkylation by the "left half" of azinomycin B.
    Zang H; Gates KS
    Biochemistry; 2000 Dec; 39(48):14968-75. PubMed ID: 11101313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the azinomycin naphthoate and central amide in sequence-dependent DNA alkylation and cytotoxicity of epoxide-bearing substructures.
    Coleman RS; Burk CH; Navarro A; Brueggemeier RW; Diaz-Cruz ES
    Org Lett; 2002 Oct; 4(20):3545-8. PubMed ID: 12323065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of functional "top-half" partial structures of azinomycin a and B.
    Coleman RS; Tierney MT; Cortright SB; Carper DJ
    J Org Chem; 2007 Sep; 72(20):7726-35. PubMed ID: 17824658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA cross-linking by azinomycin B: Monte Carlo simulations in the evaluation of sequence selectivity.
    Alcaro S; Ortuso F; Coleman RS
    J Med Chem; 2002 Feb; 45(4):861-70. PubMed ID: 11831897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: potential for development of tumor-selective N-oxides.
    Pors K; Shnyder SD; Teesdale-Spittle PH; Hartley JA; Zloh M; Searcey M; Patterson LH
    J Med Chem; 2006 Nov; 49(24):7013-23. PubMed ID: 17125254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the origin of the DNA sequence selectivity of the azinomycins.
    LePla RC; Landreau CA; Shipman M; Jones GD
    Org Biomol Chem; 2005 Apr; 3(7):1174-5. PubMed ID: 15785803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linking and sequence specific alkylation of DNA BY aziridinylquinones. 1. Quinone methides.
    Mayalarp SP; Hargreaves RH; Butler J; O'Hare CC; Hartley JA
    J Med Chem; 1996 Jan; 39(2):531-7. PubMed ID: 8558523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the molecular origin of the azinomycin epoxide: timing of the biosynthesis revealed.
    Sharma V; Kelly GT; Watanabe CM
    Org Lett; 2008 Nov; 10(21):4815-8. PubMed ID: 18841989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin dimers: polyfunctional cross-linkers of DNA.
    Paz MM; Kumar GS; Glover M; Waring MJ; Tomasz M
    J Med Chem; 2004 Jun; 47(12):3308-19. PubMed ID: 15163210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1,12-diaziridinyl-4,9-diazadodecane.
    Li Y; Eiseman JL; Sentz DL; Rogers FA; Pan SS; Hu LT; Egorin MJ; Callery PS
    J Med Chem; 1996 Jan; 39(1):339-41. PubMed ID: 8568824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles.
    Parker LL; Anderson FM; O'Hare CC; Lacy SM; Bingham JP; Robins DJ; Hartley JA
    Bioorg Med Chem; 2005 Apr; 13(7):2389-95. PubMed ID: 15755641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselectivity, sequence specificity and mechanism of action of the azinomycin epoxide.
    David-Cordonnier MH; Casely-Hayford M; Kouach M; Briand G; Patterson LH; Bailly C; Searcey M
    Chembiochem; 2006 Nov; 7(11):1658-61. PubMed ID: 16991169
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical synthesis and cytotoxicity of some azinomycin analogues devoid of the 1-azabicyclo[3.1.0]hexane subunit.
    Hodgkinson TJ; Kelland LR; Shipman M; Suzenet F
    Bioorg Med Chem Lett; 2000 Feb; 10(3):239-41. PubMed ID: 10698444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumour antibiotics with potent activity against multidrug resistant (MDR) Staphylococcus aureus: a new approach to targeting resistant bacteria.
    Casely-Hayford MA; Kerr NO; Smith E; Gibbons S; Searcey M
    Med Chem; 2005 Nov; 1(6):619-27. PubMed ID: 16787345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.